Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 53

Cited In for PubMed (Select 3788613)

1.

A concurrent excitation and inhibition of dopaminergic subpopulations in response to nicotine.

Eddine R, Valverde S, Tolu S, Dautan D, Hay A, Morel C, Cui Y, Lambolez B, Venance L, Marti F, Faure P.

Sci Rep. 2015 Feb 2;5:8184. doi: 10.1038/srep08184.

2.

Dopamine function in cigarette smokers: an [¹⁸F]-DOPA PET study.

Bloomfield MA, Pepper F, Egerton A, Demjaha A, Tomasi G, Mouchlianitis E, Maximen L, Veronese M, Turkheimer F, Selvaraj S, Howes OD.

Neuropsychopharmacology. 2014 Sep;39(10):2397-404. doi: 10.1038/npp.2014.87. Epub 2014 Apr 10.

PMID:
24718373
3.

Antipsychotic medication and tobacco use among outpatients with schizophrenia: a cross-sectional study.

Wijesundera H, Hanwella R, de Silva VA.

Ann Gen Psychiatry. 2014 Mar 19;13(1):7. doi: 10.1186/1744-859X-13-7.

4.

In vivo evidence for β2 nicotinic acetylcholine receptor subunit upregulation in smokers as compared with nonsmokers with schizophrenia.

Esterlis I, Ranganathan M, Bois F, Pittman B, Picciotto MR, Shearer L, Anticevic A, Carlson J, Niciu MJ, Cosgrove KP, D'Souza DC.

Biol Psychiatry. 2014 Sep 15;76(6):495-502. doi: 10.1016/j.biopsych.2013.11.001. Epub 2013 Nov 13.

PMID:
24360979
5.

Dopamine D₂ and acetylcholine α7 nicotinic receptors have subcellular distributions favoring mediation of convergent signaling in the mouse ventral tegmental area.

Garzón M, Duffy AM, Chan J, Lynch MK, Mackie K, Pickel VM.

Neuroscience. 2013 Nov 12;252:126-43. doi: 10.1016/j.neuroscience.2013.08.008. Epub 2013 Aug 15.

6.

Molecules and circuits involved in nicotine addiction: The many faces of smoking.

Picciotto MR, Mineur YS.

Neuropharmacology. 2014 Jan;76 Pt B:545-53. doi: 10.1016/j.neuropharm.2013.04.028. Epub 2013 Apr 28. Review.

7.

Selective breeding for high alcohol preference increases the sensitivity of the posterior VTA to the reinforcing effects of nicotine.

Hauser SR, Bracken AL, Deehan GA Jr, Toalston JE, Ding ZM, Truitt WA, Bell RL, McBride WJ, Rodd ZA.

Addict Biol. 2014 Sep;19(5):800-11. doi: 10.1111/adb.12048. Epub 2013 Mar 18.

PMID:
23496648
8.
9.

Acetylcholine as a neuromodulator: cholinergic signaling shapes nervous system function and behavior.

Picciotto MR, Higley MJ, Mineur YS.

Neuron. 2012 Oct 4;76(1):116-29. doi: 10.1016/j.neuron.2012.08.036. Review.

10.
11.

The role of fatty acid amide hydrolase inhibition in nicotine reward and dependence.

Muldoon PP, Lichtman AH, Parsons LH, Damaj MI.

Life Sci. 2013 Mar 19;92(8-9):458-62. doi: 10.1016/j.lfs.2012.05.015. Epub 2012 Jun 12. Review.

12.

Galantamine, an acetylcholinesterase inhibitor and positive allosteric modulator of nicotinic acetylcholine receptors, attenuates nicotine taking and seeking in rats.

Hopkins TJ, Rupprecht LE, Hayes MR, Blendy JA, Schmidt HD.

Neuropsychopharmacology. 2012 Sep;37(10):2310-21. doi: 10.1038/npp.2012.83. Epub 2012 Jun 6.

13.

Neurophysiology of Nicotine Addiction.

Dani JA, Jenson D, Broussard JI, De Biasi M.

J Addict Res Ther. 2011 Apr 20;S1(1). pii: 001.

14.

Lower ß2*-nicotinic acetylcholine receptor availability in smokers with schizophrenia.

D'Souza DC, Esterlis I, Carbuto M, Krasenics M, Seibyl J, Bois F, Pittman B, Ranganathan M, Cosgrove K, Staley J.

Am J Psychiatry. 2012 Mar;169(3):326-34. doi: 10.1176/appi.ajp.2011.11020189.

15.

Subregion-Specific Modulation of Excitatory Input and Dopaminergic Output in the Striatum by Tonically Activated Glycine and GABA(A) Receptors.

Adermark L, Clarke RB, Ericson M, Söderpalm B.

Front Syst Neurosci. 2011 Oct 18;5:85. doi: 10.3389/fnsys.2011.00085. eCollection 2011.

16.

A neural correlate of predicted and actual reward-value information in monkey pedunculopontine tegmental and dorsal raphe nucleus during saccade tasks.

Okada K, Nakamura K, Kobayashi Y.

Neural Plast. 2011;2011:579840. doi: 10.1155/2011/579840. Epub 2011 Oct 12. Review.

17.

α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease.

Quik M, Wonnacott S.

Pharmacol Rev. 2011 Dec;63(4):938-66. doi: 10.1124/pr.110.003269. Review.

18.

Evaluation of the effects of rivastigmine on cigarette smoking by methamphetamine-dependent volunteers.

De la Garza R 2nd, Yoon JH.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Dec 1;35(8):1827-30. doi: 10.1016/j.pnpbp.2011.07.006. Epub 2011 Jul 22.

19.

Smoke extracts and nicotine, but not tobacco extracts, potentiate firing and burst activity of ventral tegmental area dopaminergic neurons in mice.

Marti F, Arib O, Morel C, Dufresne V, Maskos U, Corringer PJ, de Beaurepaire R, Faure P.

Neuropsychopharmacology. 2011 Oct;36(11):2244-57. doi: 10.1038/npp.2011.112. Epub 2011 Jun 29.

20.

Historical and current perspective on tobacco use and nicotine addiction.

Dani JA, Balfour DJ.

Trends Neurosci. 2011 Jul;34(7):383-92. doi: 10.1016/j.tins.2011.05.001. Epub 2011 Jun 21. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk